Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3⁺ Regulatory T Cells (Tregs) in Human Cancers-Response

Affiliations

• ¹ Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
• ² Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
• ³ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
• ⁴ Department of Hematology and Oncology, University of California Los Angeles, Los Angeles, California.
• ⁵ Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. PadSharma@mdanderson.org.